ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,607Medicare Part D Prescriptions Filled, Including Refills

Rank: 58 out of 1000

$995K Total Retail Price of All Prescriptions

Rank: 55 out of 1000

378 Patients Receiving at Least One Drug in Part D
38%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

29% of this provider’s 378 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

56% of this provider’s 378 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

6% of this provider’s 7,525 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

55 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 2,537 871 S3 1 1
METOPROLOL SUCCINATE 814 329 2 21
LISINOPRIL 765 267 3 5
PRAVASTATIN SODIUM 742 254 4 12
OMEPRAZOLE 725 227 5 2
METHOCARBAMOL 475 118 R 6 79
LISINOPRIL-HYDROCHLOROTHIAZIDE 467 202 7 20
GABAPENTIN 437 105 8 11
ZOLPIDEM TARTRATE 412 105 9 16
CARVEDILOL 376 185 10 15
PROMETHAZINE HCL 375 113 R 11 54
FUROSEMIDE 323 171 12 7
LEVOTHYROXINE SODIUM 321 155 13 4
METFORMIN HCL 320 127 14 8
ENDOCET 302 34 S2 15 107
SERTRALINE HCL 301 96 16 26
TIZANIDINE HCL 287 27 17 76
MORPHINE SULFATE ER 247 50 S2 18 143
SIMVASTATIN 237 112 19 3
POTASSIUM CHLORIDE 234 134 20 10
OXYCODONE HCL 232 52 S2 21 118
PROAIR HFA 231 63 22 50
NEXIUM 221 36 23 23
RANITIDINE HCL 219 134 24 37
SPIRIVA 212 68 25 64
OXYCONTIN 207 17 S2 26 166
VENTOLIN HFA 202 66 27 83
AMLODIPINE BESYLATE 193 87 28 6
CARISOPRODOL 185 40 R 29 72
CLOPIDOGREL 180 107 30 35
FENOFIBRATE 169 71 31 55
SYMBICORT 168 40 32 149
AMITRIPTYLINE HCL 164 58 R 33 45
ADVAIR DISKUS 158 67 34 65
CYCLOBENZAPRINE HCL 158 42 R 34 39
FLUOXETINE HCL 157 31 36 51
NIFEDICAL XL 141 75 37 232
NIFEDIPINE ER 138 72 38 130
ZETIA 137 48 39 95
NIASPAN 135 73 40 172
METOPROLOL TARTRATE 126 58 41 19
LYRICA 122 42 42 47
WARFARIN SODIUM 120 89 43 22
HYDROCHLOROTHIAZIDE 117 31 44 9
AZITHROMYCIN 101 34 45 36
PLAVIX 100 68 46 49
MELOXICAM 97 0 47 14
CRESTOR 96 55 48 30
TRAZODONE HCL 96 46 48 29
SINGULAIR 91 28 50 84
PAROXETINE HCL 89 32 51 63
FLUTICASONE PROPIONATE 85 31 52 40
JANUVIA 84 47 53 85
CYMBALTA 83 12 54 53
LOVASTATIN 81 75 55 41
ESCITALOPRAM OXALATE 79 21 56 60
CLONIDINE HCL 78 33 57 27
MUPIROCIN 77 22 58 140
MONTELUKAST SODIUM 75 28 59 132
PANTOPRAZOLE SODIUM 72 29 60 28
IBUPROFEN 71 12 61 94
LEVOFLOXACIN 69 27 62 73
AMOX TR-POTASSIUM CLAVULANATE 69 21 62 125
DIGOXIN 69 58 62 52
ATORVASTATIN CALCIUM 66 11 65 18
NAPROXEN 66 0 65 81
PREDNISONE 65 25 67 42
TRICOR 64 31 68 141
AMPHETAMINE SALT COMBO 64 0 S2 68 223
CELEBREX 63 0 70 98
ACTOS 63 35 70 119
ISOSORBIDE MONONITRATE ER 57 34 72 71
TRILIPIX 55 11 73 218
SUBOXONE 54 0 74 163
VENLAFAXINE HCL 53 0 75 259
GEMFIBROZIL 52 39 76 105
ROPINIROLE HCL 52 22 76 82
DICLOFENAC SODIUM 51 39 78 123
PREMARIN 51 0 R 78 109
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.